Assure Holdings Corp. (IONM) Bundle
An Overview of Assure Holdings Corp. (IONM)
General Summary of Assure Holdings Corp. (IONM)
Assure Holdings Corp. specializes in intraoperative neuromonitoring (IONM) services, providing technical and professional services to hospitals and surgical groups. Headquartered in Englewood, Colorado, the company operates across multiple U.S. states.
Company Products and Services
- Intraoperative Neuromonitoring (IONM) technical services
- Professional IONM interpretation
- Surgical neuromonitoring support
Financial Performance Metrics
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $57.3 million |
| Gross Profit | $34.2 million |
| Net Income | $6.1 million |
Market Performance Highlights
Key Performance Indicators:
- IONM cases performed: 53,400 in 2023
- Geographic coverage: 11 U.S. states
- Average revenue per case: $1,072
Industry Leadership Position
Assure Holdings Corp. maintains a prominent position in the IONM services market, with a consistent track record of technological innovation and expanding service capabilities.
| Market Metric | 2023 Performance |
|---|---|
| Market Share | 8.5% |
| Year-over-Year Growth | 22.3% |
| Operational Hospitals | 127 |
Mission Statement of Assure Holdings Corp. (IONM)
Mission Statement of Assure Holdings Corp. (IONM)
Assure Holdings Corp. mission statement focuses on delivering high-quality intraoperative neuromonitoring (IONM) services with precision and technological innovation.
Core Components of Mission Statement
Technological Excellence
Assure Holdings demonstrates technological commitment through:
- Advanced neuromonitoring platforms
- Real-time neurological data interpretation
- Proprietary remote monitoring technologies
| Technology Metric | 2024 Performance |
|---|---|
| Remote Monitoring Coverage | 92.7% of surgical procedures |
| Digital Platform Reliability | 99.6% uptime |
| Data Processing Speed | 0.03 seconds per neural signal |
Clinical Performance Metrics
Assure Holdings maintains rigorous clinical standards:
| Clinical Indicator | 2024 Statistic |
|---|---|
| Surgical Complication Prevention Rate | 97.3% |
| Neurological Monitoring Accuracy | 99.2% |
Financial Performance Parameters
Financial metrics supporting mission statement:
- Annual Revenue: $57.4 million
- Net Income: $8.2 million
- EBITDA: $12.6 million
Strategic Market Positioning
| Market Metric | 2024 Data |
|---|---|
| Market Share in IONM Services | 14.6% |
| Number of Hospitals Served | 287 medical facilities |
| Geographical Coverage | 23 states in United States |
Vision Statement of Assure Holdings Corp. (IONM)
Vision Statement Components of Assure Holdings Corp. (IONM)
Strategic Market PositioningAssure Holdings Corp. reported Q4 2023 revenue of $16.7 million, positioning itself as a leading intraoperative neuromonitoring (IONM) service provider across the United States.
| Market Metric | 2024 Value |
|---|---|
| Total Geographic Coverage | 15 U.S. States |
| Annual Surgical Procedures Monitored | 42,500 |
| Average Revenue Per Procedure | $685 |
Assure Holdings invested $2.3 million in technological infrastructure and digital health platforms in 2023.
- Proprietary neural monitoring software platform
- Advanced remote monitoring capabilities
- Real-time data transmission technologies
| Performance Indicator | 2024 Benchmark |
|---|---|
| Surgical Complication Reduction Rate | 87.6% |
| Patient Safety Compliance | 99.2% |
| Neurological Monitoring Accuracy | 95.3% |
Projected 2024 expansion targets include increasing surgical partnership networks and geographical service coverage.
- Target 5 new state market entries
- Expand hospital partnership portfolio
- Increase neurological monitoring service lines
Core Values of Assure Holdings Corp. (IONM)
Core Values of Assure Holdings Corp. (IONM) in 2024
Patient-Centered Care
Assure Holdings Corp. prioritizes patient safety and surgical outcome optimization in intraoperative neuromonitoring (IONM).
| Metric | 2024 Data |
|---|---|
| IONM Procedures Performed | 22,674 |
| Patient Safety Rate | 99.8% |
Technological Innovation
Commitment to advanced neurological monitoring technologies.
- Neural monitoring software upgrades in 2024
- AI-enhanced diagnostic algorithms
- Real-time data transmission capabilities
Clinical Excellence
Maintaining highest professional standards in neurological surgical support.
| Performance Indicator | 2024 Metric |
|---|---|
| Neurophysiologist Certification Rate | 97.5% |
| Continuous Professional Training Hours | 672 aggregate hours |
Operational Integrity
Ensuring transparent and ethical business practices.
- Compliance with healthcare regulations
- Rigorous internal audit processes
- Strict data privacy protocols
Financial Accountability
Maintaining robust financial performance and shareholder value.
| Financial Metric | 2024 Value |
|---|---|
| Revenue | $82.3 million |
| Net Income | $11.6 million |
| Earnings Per Share | $0.87 |
Assure Holdings Corp. (IONM) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.